Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6531)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 21, 2022 (publication date) through Jul 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Delvecchio FR, Goulart MR, Fincham REA, Bombadieri M, Kocher HM. B cells in pancreatic cancer stroma. World J Gastroenterol 2022; 28(11): 1088-1101 [PMID: 35431504 DOI: 10.3748/wjg.v28.i11.1088] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i11/1088.htm |
| Number | Citing Articles |
| 1 |
Nebojsa Skorupan, Mayrel Palestino Dominguez, Samuel L. Ricci, Christine Alewine. Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma. Cancers 2022; 14(17): 4209 doi: 10.3390/cancers14174209
|
| 2 |
Jason L. Guo, David M. Lopez, Shamik Mascharak, Deshka S. Foster, Anum Khan, Michael F. Davitt, Alan T. Nguyen, Austin R. Burcham, Malini S. Chinta, Nicholas J. Guardino, Michelle Griffin, Elisabeth Miller, Michael Januszyk, Shyam S. Raghavan, Teri A. Longacre, Daniel J. Delitto, Jeffrey A. Norton, Michael T. Longaker. Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic Cancer. Tissue Engineering Part A 2024; doi: 10.1089/ten.tea.2024.0039
|
| 3 |
Jinglong Guo, Siyue Wang, Qi Gao. An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1258538
|
| 4 |
Xinlei Zou, Canghai Guan, Jianjun Gao, Wujiang Shi, Yunfu Cui, Xiangyu Zhong. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1222719
|
| 5 |
Yuanhua Nie, Longwen Xu, Zilong Bai, Yaoyao Liu, Shilong Wang, Qingnuo Zeng, Xuan Gao, Xuefeng Xia, Dongmin Chang. Prognostic utility of TME-associated genes in pancreatic cancer. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1218774
|
| 6 |
Aydar Khabipov, Dung Nguyen Trung, Julia van der Linde, Lea Miebach, Maik Lenz, Felix Erne, Wolfram von Bernstorff, Tobias Schulze, Stephan Kersting, Sander Bekeschus, Lars Ivo Partecke. CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice. Biomedicines 2023; 11(6): 1517 doi: 10.3390/biomedicines11061517
|
| 7 |
Wenqiang Xie, Jinjin Lu, Yichen Chen, Xi Wang, Huanzi Lu, Qunxing Li, Nianqiang Jin, Jiankang He, Lingling Ou, Jia Ni, Yuqin Shen, Longquan Shao. TCL1A-expressing B cells are critical for tertiary lymphoid structure formation and the prognosis of oral squamous cell carcinoma. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05292-7
|
| 8 |
Pamela Winnie M. Maimela, Muneerah Smith, Andrew J. M. Nel, Suba Dharshanan P. Bernam, Eduard G. Jonas, Jonathan M. Blackburn. Humoral immunoprofiling identifies novel biomarkers and an immune suppressive autoantibody phenotype at the site of disease in pancreatic ductal adenocarcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1330419
|
| 9 |
Justin K. Messex, Geou-Yarh Liou. Impact of Immune Cells in the Tumor Microenvironment of Prostate Cancer Metastasis. Life 2023; 13(2): 333 doi: 10.3390/life13020333
|
| 10 |
Tha Luong, Yuvasri Golivi, Ganji Purnachandra Nagaraju, Bassel F. El-Rayes. Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy. Cytokine & Growth Factor Reviews 2022; 68: 107 doi: 10.1016/j.cytogfr.2022.09.001
|
| 11 |
Yinghong Wang, Hong Zhou, Yancai Sun, Yan Huang. Acid-sensing ion channel 1: potential therapeutic target for tumor. Biomedicine & Pharmacotherapy 2022; 155: 113835 doi: 10.1016/j.biopha.2022.113835
|
| 12 |
Weili Jia, Tianchen Zhang, Qianyun Yao, Jianhui Li, Ye Nie, Xinjun Lei, Zhenzhen Mao, Yanfang Wang, Wen Shi, Wenjie Song. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.870458
|
| 13 |
Aimy Sebastian, Kelly A. Martin, Ivana Peran, Nicholas R. Hum, Nicole F. Leon, Beheshta Amiri, Stephen P. Wilson, Matthew A. Coleman, Elizabeth K. Wheeler, Stephen W. Byers, Gabriela G. Loots. Loss of Cadherin-11 in pancreatic ductal adenocarcinoma alters tumor-immune microenvironment. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1286861
|
| 14 |
Janelle M. Montagne, Elizabeth M. Jaffee, Elana J. Fertig. Multiomics Empowers Predictive Pancreatic Cancer Immunotherapy. The Journal of Immunology 2023; 210(7): 859 doi: 10.4049/jimmunol.2200660
|
| 15 |
Takayuki MINESHIGE, Yusuke TANAKA, Kenichi WATANABE, Michihito TAGAWA, Mizuki TOMIHARI, Yoshiyasu KOBAYASHI. Histologic, immunohistochemical, and <i>in situ</i> hybridization study of myxoid stroma in feline oral squamous cell carcinoma. Journal of Veterinary Medical Science 2024; 86(3): 258 doi: 10.1292/jvms.23-0356
|
| 16 |
Zeynep Nur Senturk, Isilay Akdag, Bahar Deniz, Ayca Sayi-Yazgan. Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1152551
|
| 17 |
Ou Li, Li Li, Yunru Sheng, Kun Ke, Jianzhang Wu, Yiping Mou, Mingyang Liu, Weiwei Jin. Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular. Cancer Letters 2023; 574: 216391 doi: 10.1016/j.canlet.2023.216391
|
| 18 |
Casper W.F. van Eijck, Sergio Sabroso-Lasa, Gaby J. Strijk, Dana A.M. Mustafa, Amine Fellah, Bas Groot Koerkamp, Núria Malats, Casper H.J. van Eijck. A liquid biomarker signature of inflammatory proteins accurately predicts early pancreatic cancer progression during FOLFIRINOX chemotherapy. Neoplasia 2024; 49: 100975 doi: 10.1016/j.neo.2024.100975
|